| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/04/2007 | EP1769804A2 Method of increasing bone toughness and stiffness and reducing fractures |
| 04/04/2007 | EP1769803A1 Diagnostics for, medicaments and cosmetics comprising an assembly chaperone for a complex involved in oxidative phosphorylation |
| 04/04/2007 | EP1769802A1 NFκB ACTION INHIBITOR AND ANTIINFLAMMATORY AGENT, AND STEROID ACTION FORTIFIER |
| 04/04/2007 | EP1769790A1 Preparations for the intranasal application of selected CGRP antagonists derived from amino acids |
| 04/04/2007 | EP1769066A2 Modified antigen-presenting cells |
| 04/04/2007 | EP1768999A2 B7-dc binding antibody |
| 04/04/2007 | EP1768994A2 Cyclic peptide antibiotics |
| 04/04/2007 | EP1768993A2 The cysteine-rich region of respiratory syncytial virus and methods of use therefor |
| 04/04/2007 | EP1768951A2 Non-natural amino acids |
| 04/04/2007 | EP1768696A2 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 04/04/2007 | EP1768694A1 Phamaceutical preparations comprising insulin |
| 04/04/2007 | EP1768693A1 Use of hmgb1 for wound healing |
| 04/04/2007 | EP1768691A2 Aequorin-containing compositions and methods of using same |
| 04/04/2007 | EP1768690A1 Methods or use of lamin b1 nuclear antigen, fragments and compositions thereof, for inhibiting or reducing a thrombotic event |
| 04/04/2007 | EP1768689A1 Compositions and methods for treatment of cardiovascular disease |
| 04/04/2007 | EP1768688A2 Oral vaccine for borrelia |
| 04/04/2007 | EP1768687A2 Methods and compositions related to the modulation of intercellular junctions |
| 04/04/2007 | EP1768686A2 Pegylation of vasoactive intestinal peptide (vip)/pituitary adenylate cyclase activating peptide (pacap) receptor 2 (vpac2) agonists and methods of use |
| 04/04/2007 | EP1768676A1 Use of compounds containing thiol groups as an efflux pump inhibitor |
| 04/04/2007 | EP1768647A1 Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agent |
| 04/04/2007 | EP1768602A2 Combination drug therapy for reducing scar tissue formation |
| 04/04/2007 | EP1768499A1 Medicinal products incorporating bound organosulfur groups |
| 04/04/2007 | EP1545584A4 Method for reducing morbidity and mortality in critically ill patients |
| 04/04/2007 | EP1443054B1 Anitmicrobial proteins, genes encoding the proteins and mehtod of using the same |
| 04/04/2007 | EP1427405B1 Inflammation-inhibiting compounds |
| 04/04/2007 | EP1414370B1 Dry hemostatic compositions and methods for their preparation |
| 04/04/2007 | EP1352056B1 Polypeptides capable of eliciting an immune reaction against cancer |
| 04/04/2007 | EP1294385B1 Method for the production of artificial oxygen carriers from covalently cross linking haemoglobin with improved functional properties of haemoglobin by cross-linking in the presence of chemically non-reacting effectors of the oxygen affinity of the haemoglobin |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | EP1137786B1 Virus coat protein/receptor chimeras and methods of use |
| 04/04/2007 | EP1117393B1 L-acetylcarnitine as antitumour agent |
| 04/04/2007 | EP1098642B1 Diamino-propanol-compounds for treating ischemia |
| 04/04/2007 | EP1054988B1 Anti-viral vectors |
| 04/04/2007 | EP1029548B1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/04/2007 | EP1028737B1 Human mesenchymal stem cells from peripheral blood |
| 04/04/2007 | EP0991756B1 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
| 04/04/2007 | EP0980203B1 Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 04/04/2007 | EP0951292B1 Treating an ischemic disorder and improving stroke outcome |
| 04/04/2007 | CN1942767A Gastric inhibitory polypeptide diagnostic test for detecting susceptibility to type-2 diabetes, impaired glucose tolerance, or impaired fasting glucose |
| 04/04/2007 | CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/04/2007 | CN1942480A Identification of SNPs associated with hyperlipidemia, dyslipidemia and defective carbohydrate metabolism |
| 04/04/2007 | CN1942206A Pharmaceutical composition for treatment of immunological disorders |
| 04/04/2007 | CN1942201A Methods of modulating cytokine activity; related reagents |
| 04/04/2007 | CN1942200A Use of low-dose erythropoietin for stimulating endothelial precursor cells, regenerating organs, and slowing down progression of end organ damages |
| 04/04/2007 | CN1942199A Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
| 04/04/2007 | CN1940075A Recombinant plasmid with human thymosin Beta-4gene |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/04/2007 | CN1940066A Production of expression vermis kinase tr-gene plant and its products |
| 04/04/2007 | CN1940065A Oriented mutant gene engineering barr kinase and its use |
| 04/04/2007 | CN1940064A Production of thrombolytic kinase (natto kinase) and its use |
| 04/04/2007 | CN1939541A Immunostimulatory nucleic acids |
| 04/04/2007 | CN1939538A Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 04/04/2007 | CN1939536A Injection for treating angitis |
| 04/04/2007 | CN1939535A Composite collagen protein liquid |
| 04/04/2007 | CN1939534A Externally-applied preparation containing human growth incretion or human granular leukocyte macrophage stimulus factor for treating injury ulceration |
| 04/04/2007 | CN1939533A Injection sarcosine peptide aglycone powdery injection and its making method |
| 04/04/2007 | CN1939532A Use of fungal immunomodulatory protein |
| 04/04/2007 | CN1939531A Use of botulinum toxin for the treatment of unstable bladder |
| 04/04/2007 | CN1939530A Freeze-drying powder injection of Bozhi glycopeptide and its preparation |
| 04/04/2007 | CN1939529A Compositions and methods for modulating connexin hemichannels |
| 04/04/2007 | CN1939343A Bone-peptide sodium chloride injection and its making method |
| 04/04/2007 | CN1939342A Injection bone peptide freeze-drying preparation and its making method |
| 04/04/2007 | CN1939341A Brain protein hydrolyte freeze-drying preparation for injection and its making method |
| 04/04/2007 | CN1939294A In-vivo filming cancer treatment |
| 04/04/2007 | CN1939288A Composite acne-inhibiting pellicle |
| 04/04/2007 | CN1308683C Process for the measurement of the potency of glatiramer acetate |
| 04/04/2007 | CN1308451C Tumor necrosis factor related ligand |
| 04/04/2007 | CN1308450C Methods and compositions for diagnosis and treatment of cancer |
| 04/04/2007 | CN1308447C Degraded agonist antibody |
| 04/04/2007 | CN1308442C Method for purifying enzyme, purified enzyme produced thereby and use of this enzyme |
| 04/04/2007 | CN1308347C Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 04/04/2007 | CN1308346C Novel human phosphotidylethanolamine binding protein, its coding sequence and application |
| 04/04/2007 | CN1308037C FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 04/04/2007 | CN1308035C Application of human urine kininogenase for preparing medicine to treat acute coronary disease |
| 04/04/2007 | CN1308034C Method of preparing microsphere of ethoxyl copolymer PLGA in interferon poly acid |
| 04/04/2007 | CN1308033C Medicine for decreasing vagina acidity and treating colpitis and use thereof |
| 04/04/2007 | CN1307999C Mixed-cell gene therapy |
| 04/03/2007 | USRE39548 Interleukin-5 specific recombinant antibodies |
| 04/03/2007 | USRE39545 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries |
| 04/03/2007 | USRE39542 Preparation of agarose coated, solid agarose-collagen beads containing secretory cells |
| 04/03/2007 | US7200531 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 04/03/2007 | US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents |
| 04/03/2007 | US7199232 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/03/2007 | US7199231 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology |
| 04/03/2007 | US7199229 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 04/03/2007 | US7199228 Nucleotide sequences comprising nebularine, hypoxanthine and uracil; antitumor agents; antiproliferative agents; anticarcinogenic agents; antiinflammatory agents |
| 04/03/2007 | US7199225 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 04/03/2007 | US7199223 Water soluble polyoxyethylene glylcol polyvinylpyrrolidone, polyvinyl alcohol, polyoxazoline, and/or polyacryloylmorpholine, conjugated to antihemophilic factor |
| 04/03/2007 | US7199222 An artificial mutant tRNA synthetase; aminoacylates an orthogonal tRNA with beta -GlcNAc-serine |
| 04/03/2007 | US7199218 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 04/03/2007 | US7199217 Amidated glucagon-like peptide-1 |
| 04/03/2007 | US7199216 Two covalently bonded peptide components, one component being an antigen associated with autoimmune disease, asthma, allergy or transplantation rejection, and the second being a T cell binding ligand modified to inhibit or suppress the activation of the class of T cells to which it selectively binds |
| 04/03/2007 | US7199215 Pseudopeptide, synthesis method, reagent and applications |
| 04/03/2007 | US7199161 Clusianon derivatives; anticarcinogenic, antitumor and viricidal agents; mixture with mitogen-activated protein (MAP) kinase inhibitors |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199103 Synthetic compounds and compositions with enhanced cell binding |
| 04/03/2007 | US7199102 Orally administered peptides synergize statin activity |
| 04/03/2007 | US7199101 N-butyl-2-(N'-(lauroyl or 2-ethylhexanoyl)amino)glutarimide and N-(lauroyl or 2-ethylhexanoyl)-L-glutamic acid dibutylamide; spreadability and high gel strength; cosmetics and antiperspirant stick; hair gels |
| 04/03/2007 | US7199100 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 04/03/2007 | US7199099 Treating grampositive bacterial infections |